Ulcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoids.
Studies in animal models and humans suggest anti-inflammatory roles on the N-acylethanolamide (NAE)-peroxisome proliferators activated receptor alpha (PPARα) system in inflammatory bowel diseases. However, the presence and function of NAE-PPARα signaling system in the ulcerative colitis (UC) of huma...
Guardado en:
Autores principales: | Juan Suárez, Yanina Romero-Zerbo, Lucia Márquez, Patricia Rivera, Mar Iglesias, Francisco J Bermúdez-Silva, Montserrat Andreu, Fernando Rodríguez de Fonseca |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a96c25e5d14c45268405caa8af6e4ebc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparison of maintenance effect of probiotics and aminosalicylates on ulcerative colitis: A meta-analysis of randomized controlled trials
por: Yong Jiang, et al.
Publicado: (2016) -
Predictive factors of relapse after dose reduction of oral 5-aminosalicylic acid in patients with ulcerative colitis in the remission phase.
por: Akira Madarame, et al.
Publicado: (2021) -
Infliximab in ulcerative colitis
por: Avi Levin, et al.
Publicado: (2008) -
Golimumab in unresponsive ulcerative colitis
por: Lippert E, et al.
Publicado: (2014) -
5-Aminosalicylic Acid Ameliorates Colitis and Checks Dysbiotic Escherichia coli Expansion by Activating PPAR-γ Signaling in the Intestinal Epithelium
por: Stephanie A. Cevallos, et al.
Publicado: (2021)